FDA Approved: IYUZEH — Original Application (Thea Pharma Inc.)

View source ↗

Summary

FDA approved IYUZEH, latanoprost ophthalmic solution 0.005%, under an original NDA from Thea Pharma Inc. for reducing intraocular pressure in open-angle glaucom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• IYUZEH (LATANOPROST OPHTHALMIC SOLUTION 0.005%)

Snippet

ORIG AP for IYUZEH (LATANOPROST OPHTHALMIC SOLUTION 0.005%)